Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDY-5301 in patients undergoing unilateral total knee arthroplasty with tourniquet use
ACTRN12618001014246Phase 2Completed
- Sponsor
- Faraday Pharmaceuticals
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in Sarcopenia comparing FDY-5301 with Placebo (2 arms). Primary endpoint: Stair ascent and descent functional mobility assessment. Started Sep 2018; status: completed.
02
Drugs
Sodium iodide
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on ACTRN12618001014246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001014246.